Industry’s First-Ever Female CEO Aims to Get under Women’s Skin
London, UK – 24 June, 2013 – In the wake of a health scandal which saw over 300,000 women worldwide fitted with defective medical devices and a loss of confidence in the sector, one of the world’s leading manufacturers of breast implants today announces they will be tackling the challenges under the guidance of the industry’s first-ever female Chief Executive Officer. GC Aesthetics (www.gcaesthetics.com), the parent company of international brands Eurosilicone and UK-based Nagor; whose products are sold in over 90 countries; will be led through a female consumer-focused re-launch by former Pfizer executive and biotech firm Vice President Ms. Ayse Kocak.
Ayse, who has been recognised as one of the top 100 Most Powerful Women in Mexico by CNN Expansion magazine, aims to mould GC Aesthetics and its 300+ employees into a company that speaks directly to women and caters to their needs. Her appointment heralds a new era for GC Aesthetics, coinciding with the arrival of a new and like-minded female Global Brand Director, Faye Mingo, based in London. Ayse says;
“At this seminal time in our sector, we have a tremendous opportunity to fundamentally change the playing field of the breast implant industry. All businesses have an obvious need to be aligned with what their consumers want, and in our case it’s specifically about what women want.”
GC Aesthetics aims to become the leading independent medical aesthetics company worldwide by 2015; it owns French brand Eurosilicone (www.eurosilicone.com) and the UK’s only breast implant manufacturer Nagor (www.nagor.com) which together produce over 275,000 implants each year in a wide product range with nearly 600 unique types varying in shape, texture and projection. Their products have been on the market for over thirty years and offer the best warranty available: free and valid for the entirety of the patients’ lifetime, rather than just the product’s lifetime. Ayse continues;
“We want to make sure that women are fully informed, and therefore empowered, in making their decision. We understand that it’s not just the physical aspect of breast enhancement or reconstruction, but how women feel about their choice to have breast implants placed inside their bodies. One of our key objectives is to provide clear, uniquely tailored materials that speak to the female consumer.
“We’re not simply making and selling medical devices; we’re helping women change they way they feel about themselves, so they can make the lifestyle choice that is right for them.”
According to Global Brand Director Faye Mingo, who worked at UK pregnancy and baby company Bounty and global personal and healthcare company Kimberly Clark before joining GC Aesthetics;
“We’re excited to be putting into place extensive plans to further establish our company as one that genuinely listens and responds to women – getting ‘under the skin’ of the issues that they face when considering breast procedures. We want to encourage them to do thorough research and offer a platform to share their experiences with each other. The public has certainly become more aware that choosing the implant is as important as choosing the surgeon.”
GC Aesthetics’ new initiatives aren’t limited to the consumer alone – the company also intends to further promote their open-door policy for surgeons to visit the manufacturing facilities and see first-hand how the products are made.